Ception Therapeutics
Ception Therapeutics is a biopharmaceutical company developing novel products to address areas of unmet medical needs.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Ception Therapeutics Information
Ception Therapeutics was acquired by
Cephalon.
The acquisition happend on 2010-02-23.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Malvern
State: Pennsylvania
Zip:
Country: United States
Financial Info
Stage:
series c
Raised Last:
$15M
Raised Total:$78M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Ception Therapeutics is a biopharmaceutical company focused on the discovery and development of novel products to address areas of unmet medical need. Ception was founded by experienced pharmaceutical executives in order to develop and commercialize therapeutics in areas of significant unmet medical need.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2007 | Series C | $0 |
Greenlight Capital Third Point Ventures Greenlight Capital Third Point Ventures |
1/2007 | Series C | 5 | $63M |
Aperture Venture Partners Essex Woodlands Healthcare Partners Growth Capital Fund MDS Capital New Science Ventures Aperture Venture Partners Essex Woodlands Healthcare Partners Growth Capital Fund MDS Capital New Science Ventures |
5/2007 | Series C | 2 | $14.7M |
Greenlight Capital Third Point Ventures Greenlight Capital Third Point Ventures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
